Diabetes, Type I

Explore clinical trials studying Diabetes, Type I. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Diabetes, Type I trial results

Not Yet Recruiting

A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes

NCT06938334

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: Azienda Ospedale-Università Padova Padova, Italia, Italy

View Trial Details

Completed

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

NCT01754259

Conditions: Angina, Angina Pectoris, Arterial Occlusive Diseases, +23 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm

NCT00541515

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: schneider children medical center of Israel Petah Tikva, Israel

View Trial Details

Completed

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

NCT00308308

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: Coastal Clinical Research Inc Mobile, Alabama, United States

Radiant Research (Phoenix) Chandler, Arizona, United States

International Clinical Research Network Chula Vista, California, United States

Family Medical Center Foothill Ranch, California, United States

View all 129 locations

View Trial Details

Completed

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

NCT00810589

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: Medical University Graz Graz, Austria

View Trial Details

Completed

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

NCT00046150

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: Hospital de Rangueil Toulouse, France

Sanofi-aventis Administrative Office Berlin, Germany

Sanofi-aventis Administrative Office Gouda, Netherlands

View Trial Details

Completed

Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives

NCT00654121

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: Universitair Ziekenhuis Antwerpen Antwerp, Belgium

Academisch Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB Brussels, Belgium

Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL Leuven, Belgium

View Trial Details

Diabetes, Type I

Diabetes, Type I trial results

A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.

Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives

Related conditions